AI
| Followers | 842 |
| Posts | 122793 |
| Boards Moderated | 10 |
| Alias Born | 09/05/2002 |
Sunday, December 21, 2008 4:49:56 PM
MK-7009 Phase-1b Results
[These charts have a little more detail than
what MRK presented on its Dec 9 R&D webcast.
The data look very good indeed, and MK-7009
could be a serious player in the HCV PI arena.
Unfortunately for investors, we probably won’t
get any data from the phase-2a trial until AASLD
2009 or MRK’s next R&D Day in Dec 2009.]
Efficacy data:
Safety data
(AE’s with >=2 cases in all cohorts combined):
Source: http://www.natap.org/2008/AASLD/AASLD_09.htm
[These charts have a little more detail than
what MRK presented on its Dec 9 R&D webcast.
The data look very good indeed, and MK-7009
could be a serious player in the HCV PI arena.
Unfortunately for investors, we probably won’t
get any data from the phase-2a trial until AASLD
2009 or MRK’s next R&D Day in Dec 2009.]
Efficacy data:
Safety data
(AE’s with >=2 cases in all cohorts combined):
Source: http://www.natap.org/2008/AASLD/AASLD_09.htm
Trade Smarter with Thousands
Leverage decades of market experience shared openly.
